Correlation Between Abnova Taiwan and Sinphar Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Abnova Taiwan and Sinphar Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abnova Taiwan and Sinphar Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Abnova Taiwan Corp and Sinphar Pharmaceutical Co, you can compare the effects of market volatilities on Abnova Taiwan and Sinphar Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abnova Taiwan with a short position of Sinphar Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abnova Taiwan and Sinphar Pharmaceutical.
Diversification Opportunities for Abnova Taiwan and Sinphar Pharmaceutical
0.82 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Abnova and Sinphar is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Abnova Taiwan Corp and Sinphar Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sinphar Pharmaceutical and Abnova Taiwan is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abnova Taiwan Corp are associated (or correlated) with Sinphar Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sinphar Pharmaceutical has no effect on the direction of Abnova Taiwan i.e., Abnova Taiwan and Sinphar Pharmaceutical go up and down completely randomly.
Pair Corralation between Abnova Taiwan and Sinphar Pharmaceutical
Assuming the 90 days trading horizon Abnova Taiwan Corp is expected to under-perform the Sinphar Pharmaceutical. But the stock apears to be less risky and, when comparing its historical volatility, Abnova Taiwan Corp is 1.06 times less risky than Sinphar Pharmaceutical. The stock trades about -0.04 of its potential returns per unit of risk. The Sinphar Pharmaceutical Co is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 3,080 in Sinphar Pharmaceutical Co on August 25, 2024 and sell it today you would earn a total of 35.00 from holding Sinphar Pharmaceutical Co or generate 1.14% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Abnova Taiwan Corp vs. Sinphar Pharmaceutical Co
Performance |
| Timeline |
| Abnova Taiwan Corp |
| Sinphar Pharmaceutical |
Abnova Taiwan and Sinphar Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Abnova Taiwan and Sinphar Pharmaceutical
The main advantage of trading using opposite Abnova Taiwan and Sinphar Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abnova Taiwan position performs unexpectedly, Sinphar Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sinphar Pharmaceutical will offset losses from the drop in Sinphar Pharmaceutical's long position.| Abnova Taiwan vs. Sinphar Pharmaceutical Co | Abnova Taiwan vs. Wellell | Abnova Taiwan vs. Phytohealth Corp | Abnova Taiwan vs. YungShin Global Holding |
| Sinphar Pharmaceutical vs. CHC Healthcare Group | Sinphar Pharmaceutical vs. GenMont Biotech | Sinphar Pharmaceutical vs. Abnova Taiwan Corp | Sinphar Pharmaceutical vs. Wellell |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |